Segieth J - Search Results

1

A randomized phase III trial of adjunctive zonisamide in pediatric patients with partial epilepsy.

Guerrini R, Rosati A, Segieth J, Pellacani S, Bradshaw K, Giorgi L. Guerrini R, et al. Among authors: segieth j. Epilepsia. 2013 Aug;54(8):1473-80. doi: 10.1111/epi.12233. Epub 2013 Jul 9. Epilepsia. 2013. PMID: 23837461 Free article. Clinical Trial.

2

Safety and tolerability of zonisamide in elderly patients with epilepsy.

Trinka E, Giorgi L, Patten A, Segieth J. Trinka E, et al. Among authors: segieth j. Acta Neurol Scand. 2013 Dec;128(6):422-8. doi: 10.1111/ane.12162. Epub 2013 Jun 15. Acta Neurol Scand. 2013. PMID: 23773051

3

Efficacy and tolerability of zonisamide versus controlled-release carbamazepine for newly diagnosed partial epilepsy: a phase 3, randomised, double-blind, non-inferiority trial.

Baulac M, Brodie MJ, Patten A, Segieth J, Giorgi L. Baulac M, et al. Among authors: segieth j. Lancet Neurol. 2012 Jul;11(7):579-88. doi: 10.1016/S1474-4422(12)70105-9. Epub 2012 Jun 8. Lancet Neurol. 2012. PMID: 22683226 Clinical Trial.

4

Arginine release from rat cerebellar astrocytes: autocrine roles for glutamate and nitric oxide?

Segieth J, Fowler L, Whitton PS, Pearce B. Segieth J, et al. Neurosci Lett. 2004 Dec 6;372(3):262-5. doi: 10.1016/j.neulet.2004.09.049. Neurosci Lett. 2004. PMID: 15542252

5

Regulatory role of nitric oxide over extracellular taurine in the hippocampus of freely moving rats.

Watts J, Segieth J, Pearce B, Whitton PS. Watts J, et al. Among authors: segieth j. Neurosci Lett. 2004 Mar 11;357(3):179-82. doi: 10.1016/j.neulet.2003.12.056. Neurosci Lett. 2004. PMID: 15003279

6

Repeated but not acute clomipramine decreases the effect of N-methyl-D-aspartate receptor activation on serotonergic transmission between the raphe nuclei and frontal cortex.

Pallotta M, Segieth J, Sadideen F, Whitton PS. Pallotta M, et al. Among authors: segieth j. Neuropharmacology. 2001 Sep;41(3):294-300. doi: 10.1016/s0028-3908(01)00078-8. Neuropharmacology. 2001. PMID: 11522320

7

Regulatory role of nitric oxide over hippocampal 5-HT release in vivo.

Segieth J, Pearce B, Fowler L, Whitton PS. Segieth J, et al. Naunyn Schmiedebergs Arch Pharmacol. 2001 Mar;363(3):302-6. doi: 10.1007/s002100000370. Naunyn Schmiedebergs Arch Pharmacol. 2001. PMID: 11284445

8

Nitric oxide-mediated regulation of dopamine release in the hippocampus in vivo.

Segieth J, Fowler L, Whitton P, Pearce B. Segieth J, et al. Neuropharmacology. 2000 Feb 14;39(4):571-7. doi: 10.1016/s0028-3908(99)00178-1. Neuropharmacology. 2000. PMID: 10728878

9

Chronic but not acute clomipramine alters the effect of NMDA receptor regulation of dopamine release in rat frontal cortex.

Pallotta M, Segieth J, Whitton PS. Pallotta M, et al. Among authors: segieth j. Neurosci Lett. 1999 Mar 12;262(3):187-90. doi: 10.1016/s0304-3940(99)00058-0. Neurosci Lett. 1999. PMID: 10218887

10

Chronic clomipramine administration reverses NMDA-evoked decreases in dopamine release in the raphe nuclei.

Pallotta M, Segieth J, Whitton PS. Pallotta M, et al. Among authors: segieth j. Brain Res. 1999 Mar 27;823(1-2):217-20. doi: 10.1016/s0006-8993(99)01174-9. Brain Res. 1999. PMID: 10095031

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters